P43220 |
GLP1R_HUMAN |
Cardiovascular disease [ICD-11: BA00-BE2Z] |
P43220 |
GLP1R_HUMAN |
Obesity [ICD-11: 5B80-5B81] |
P43220 |
GLP1R_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P43220 |
GLP1R_HUMAN |
Type-1/2 diabete [ICD-11: 5A10-5A11] |
P43220 |
GLP1R_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P43220 |
GLP1R_HUMAN |
Diabetes mellitus [ICD-11: 5A10] |
P43220 |
GLP1R_HUMAN |
Dyspepsia [ICD-11: MD92] |
P43220 |
GLP1R_HUMAN |
Irritable bowel syndrome [ICD-11: DD91] |
P43220 |
GLP1R_HUMAN |
Intracranial injury [ICD-11: NA07] |
P43220 |
GLP1R_HUMAN |
Non-alcoholic fatty liver disease [ICD-11: DB92] |
P11511 |
CP19A_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P11511 |
CP19A_HUMAN |
Cushing syndrome [ICD-11: 5A70] |
P11511 |
CP19A_HUMAN |
Oesophagitis [ICD-11: DA24] |
P11511 |
CP19A_HUMAN |
Endometriosis [ICD-11: GA10] |
P11511 |
CP19A_HUMAN |
Neuropathy [ICD-11: 8C0Z] |
P11511 |
CP19A_HUMAN |
Bladder cancer [ICD-11: 2C94] |
P11511 |
CP19A_HUMAN |
Prostate disease [ICD-11: GA91] |
P11511 |
CP19A_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P11511 |
CP19A_HUMAN |
Cushing syndrome [ICD-11: 5A70] |
P11511 |
CP19A_HUMAN |
Oesophagitis [ICD-11: DA24] |
P11511 |
CP19A_HUMAN |
Endometriosis [ICD-11: GA10] |
P11511 |
CP19A_HUMAN |
Neuropathy [ICD-11: 8C0Z] |
P11511 |
CP19A_HUMAN |
Bladder cancer [ICD-11: 2C94] |
P11511 |
CP19A_HUMAN |
Prostate disease [ICD-11: GA91] |
Q13148 |
TADBP_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
Q13148 |
TADBP_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
P18405 |
S5A1_HUMAN |
Prostate disease [ICD-11: GA91] |
P18405 |
S5A1_HUMAN |
Acne vulgaris [ICD-11: ED80] |
P31213 |
S5A2_HUMAN |
Prostate hyperplasia [ICD-11: GA90] |